Please enable Javascript
Arun Krishna
Arun Krishna
Articles by Arun Krishna
Arun Krishna on the FLAURA2 Trial Results: Tagrisso Effectively Combats NSCLC
Arun Krishna
Non-Small Cell Lung Cancer
|
April 4, 2024
Arun Krishna, of AstraZeneca, talks about the phase 3 FLAURA2 trial, which assessed Tagrisso in patients with NSCLC.
View More
Arun Krishna, AstraZeneca: Tagrisso Proven Effective at Treating NSCLC
Arun Krishna
Non-Small Cell Lung Cancer
|
November 9, 2023
Arun Krishna, of AstraZeneca, spoke about the FLAURA2 trial, which showed the efficacy of Tagrisso in the treatment of NSCLC.
View More